Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Masanari Sugawara"'
Autor:
Hiroki Takahashi, Chisako Suzuki, Kenichi Takano, Masatoshi Kanda, Ryuta Kamekura, Masanari Sugawara, Ken Nagahata
Publikováno v:
RMD Open, Vol 9, Iss 1 (2023)
Dupilumab (DUP) is a monoclonal antibody that acts on the interleukin (IL)-4 receptor alpha, which inhibits IL-4 and IL-13 signalling and is approved for type 2 inflammatory diseases such as asthma, chronic rhinosinusitis with nasal polyposis and ato
Externí odkaz:
https://doaj.org/article/f44a7f53d7ad44569d83288b40283761
Autor:
Chisako Suzuki, Hiroki Takahashi, Masanari Sugawara, Masatoshi Kanda, Naoya Yama, Ryuta Kamekura, Ken Nagahata, Kenichi Takano, Masamitsu Hatakenaka
Publikováno v:
Annals of Nuclear Medicine. 36:200-207
Tubarial glands (TGs) are recently refocused gland tissues localized near the tori tubarius in the nasopharynx and their clinical relevance is not clear yet. IgG4-related disease (IgG4-RD) is a progressive fibrosing condition and salivary glands are
Autor:
Koki Nakamura, Masatoshi Kanda, Kenji Notohara, Masanari Sugawara, Ken Nagahata, Chisako Suzuki, Hiroki Takahashi
Publikováno v:
Internal medicine (Tokyo, Japan).
A 67-year-old woman with a 5-year history of recurrent swollen eyelids and epistaxis, diagnosed as immunoglobulin4-related diseases (IgG4-RD) based on hyper-IgG4-emia and IgG4-positive cell infiltration to the lesion, was referred to our department d
Autor:
Taiki Sato, Tatsuya Atsumi, Kenji Oku, Michihito Kono, Masanari Sugawara, Naoki Ohnishi, Olga Amengual, Yusuke Ogata, Yuichiro Fujieda, Masaru Kato
Publikováno v:
Rheumatology. 60(3):1331-1337
Objective Using cluster analysis, to identify the subgroup of patients with APS with the poorest prognosis and clarify the characteristics of that subgroup. Methods This is a longitudinal retrospective cohort study of APS patients. Using clinical dat
Autor:
Masatoshi Kanda, Ryuta Kamekura, Masanari Sugawara, Ken Nagahata, Chisako Suzuki, Kenichi Takano, Hiroki Takahashi
Publikováno v:
RMD Open. 9:e003026
Dupilumab (DUP) is a monoclonal antibody that acts on the interleukin (IL)-4 receptor alpha, which inhibits IL-4 and IL-13 signalling and is approved for type 2 inflammatory diseases such as asthma, chronic rhinosinusitis with nasal polyposis and ato
Autor:
Koki Nakamura, Masatoshi Kanda, Kenji Notohara, Masanari Sugawara, Ken Nagahata, Chisako Suzuki, Hiroki Takahashi
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 4, p637-641, 5p
Autor:
Masaru Yoshimura, Yuichiro Fujieda, Masanari Sugawara, Michihito Kono, Masaru Kato, Isao Yokota, Olga Amengual, Yoichi M. Ito, Tatsuya Atsumi
Publikováno v:
Rheumatology international. 42(11)
The objective of this study is to clarify the clinical features and risk factors of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA). We retrospectively reviewed the prevalence of VTE in RA patients who visited Hokkaido Univers
Autor:
Ken, Nagahata, Masatoshi, Kanda, Ryuta, Kamekura, Masanari, Sugawara, Naoya, Yama, Chisako, Suzuki, Kenichi, Takano, Masamitsu, Hatakenaka, Hiroki, Takahashi
Publikováno v:
Annals of nuclear medicine. 36(2)
Tubarial glands (TGs) are recently refocused gland tissues localized near the tori tubarius in the nasopharynx and their clinical relevance is not clear yet. IgG4-related disease (IgG4-RD) is a progressive fibrosing condition and salivary glands are
Autor:
Masanari, Sugawara, Yuichiro, Fujieda, Atsushi, Noguchi, Shun, Tanimura, Yuka, Shimizu, Ikuma, Nakagawa, Masaru, Yoshimura, Nobuya, Abe, Michihito, Kono, Masaru, Kato, Kenji, Oku, Olga, Amengual, Isao, Yokota, Hiroki, Takahashi, Tatsuya, Atsumi
Publikováno v:
Clinical and Experimental Rheumatology.
To identify the subpopulation of rheumatoid arthritis (RA) non-responders to Janus kinase inhibitors (JAKis) using cluster analysis.This retrospective study enrolled RA patients who had been treated with JAKis (tofacitinib or baricitinib) between Jul
Publikováno v:
Journal of Rheumatology; Jun2023, Vol. 50 Issue 6, p846-846, 1p